Literature DB >> 7832475

Blockade of VIP during neonatal development induces neuronal damage and increases VIP and VIP receptors in brain.

J M Hill1, R F Mervis, J Politi, S K McCune, I Gozes, M Fridkin, D E Brenneman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7832475     DOI： 10.1111/j.1749-6632.1994.tb19823.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  16 in total

1.  VIP, from gene to behavior and back: summarizing my 25 years of research.

Authors:  Illana Gozes
Journal:  J Mol Neurosci       Date:  2008-07-08       Impact factor: 3.444

Review 2.  A VIP hybrid antagonist: from developmental neurobiology to clinical applications.

Authors:  I Gozes; M Fridkin; D E Brenneman
Journal:  Cell Mol Neurobiol       Date:  1995-12       Impact factor: 5.046

3.  Protection against developmental deficiencies by a lipophilic VIP analogue.

Authors:  I Gozes; M Bachar; A Bardea; A Davidson; S Rubinraut; M Fridkin
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

4.  Vasoactive Intestinal Peptide Decreases β-Amyloid Accumulation and Prevents Brain Atrophy in the 5xFAD Mouse Model of Alzheimer's Disease.

Authors:  Orhan Tansel Korkmaz; Hakan Ay; Nurgul Aytan; Isabel Carreras; Neil W Kowall; Alpaslan Dedeoglu; Nese Tuncel
Journal:  J Mol Neurosci       Date:  2018-11-29       Impact factor: 3.444

5.  Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain.

Authors:  P Gressens; S Marret; J M Hill; D E Brenneman; I Gozes; M Fridkin; P Evrard
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

6.  A glia-derived signal regulating neuronal differentiation.

Authors:  O Blondel; C Collin; W J McCarran; S Zhu; R Zamostiano; I Gozes; D E Brenneman; R D McKay
Journal:  J Neurosci       Date:  2000-11-01       Impact factor: 6.167

7.  Regulation of the neurotensin NT(1) receptor in the developing rat brain following chronic treatment with the antagonist SR 48692.

Authors:  I Lépée-Lorgeoux; C Betancur; F Souazé; W Rostène; A Bérod; D Pélaprat
Journal:  J Neurosci Res       Date:  2000-05-01       Impact factor: 4.164

8.  Neonatal mice of the Down syndrome model, Ts65Dn, exhibit upregulated VIP measures and reduced responsiveness of cortical astrocytes to VIP stimulation.

Authors:  Nadia Sahir; Douglas E Brenneman; Joanna M Hill
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

9.  Regardless of genotype, offspring of VIP-deficient female mice exhibit developmental delays and deficits in social behavior.

Authors:  Maria A Lim; Conor M Stack; Katrina Cuasay; Madeleine M Stone; Hewlet G McFarlane; James A Waschek; Joanna M Hill
Journal:  Int J Dev Neurosci       Date:  2008-03-14       Impact factor: 2.457

10.  Blockage of VIP during mouse embryogenesis modifies adult behavior and results in permanent changes in brain chemistry.

Authors:  Joanna M Hill; Janet M Hauser; Lia M Sheppard; Daniel Abebe; Irit Spivak-Pohis; Michal Kushnir; Iris Deitch; Illana Gozes
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.